HUMAN FIBRINOGEN & HUMAN THROMBIN (Veraseal®)

Clinical Indication

Supportive treatment in adults where standard surgical techniques are insufficient; for improvement of haemostasis & as suture support in vascular surgery

Date of classification

September 2021

Review date

September 2021

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.